- Narrative Type
| - Narrative Text
|
| Additional Text | Please refer to the attached documents:-
(1) Circular to Shareholders dated 11 July 2023;
(2) Notice of Extraordinary General Meeting dated 11 July 2023;
(3) Proxy Form; and
(4) Request Form. |
| Additional Text | This announcement has been prepared by Biolidics Limited (the "Company") and has been reviewed by the Company s sponsor, United Overseas Bank Limited (the "Sponsor"), for compliance with Rules 226(2)(b) and 753(2) of the Singapore Exchange Securities Trading Limited ("SGX-ST") Listing Manual Section B: Rules of Catalist. |
| Additional Text | This announcement has not been examined or approved by the SGX-ST. The SGX-ST assumes no responsibility for the contents of this announcement, including the correctness of any of the statements or opinions made or reports contained in this announcement. |
| Additional Text | The contact person for the Sponsor is Mr. Lim Hoon Khiat, Senior Director, Equity Capital Markets, who can be contacted at 80 Raffles Place, #03-03 UOB Plaza 1, Singapore 048624, telephone: +65 6533 9898. |